Wexford Capital’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.68M	Sell	382,555 -25,996	-6%	-$454K	1.86%	11
2025 Q1	$5.14M	Buy	408,551 +39,054	+11%	+$491K	1.34%	17
2024 Q4	$3.9M	Buy	369,497 +121,150	+49%	+$1.28M	0.62%	29
2024 Q3	$3.6M	Buy	+248,347	New	+$3.6M	0.86%	32